Category: Technical
- Nº 10Essay
The Test That Decides Treatment: Why Companion Diagnostics Is the Most Invisible — and Most Valuable — IVD Category
Every targeted oncology drug approved in 2026 came with a mandatory test. CDx is the regulatory link between a molecular result and a treatment decision, not a product.
- Nº 08Essay
The Antibody That Half the Market Rents
Five diagnostics platforms are racing toward Alzheimer's blood testing. Two licensed the same antibody from the same small biotech. A third group hasn't entered the avenue at all.
- Nº 06Essay
The Race Nobody Can Win
Routine clinical chemistry has converged into an engineering commodity. The differentiation that actually matters has moved one floor up, into the specialised immunoassay niches where a wrong number hurts a patient.